<?xml version="1.0" encoding="UTF-8"?>
<ref id="B64-biomolecules-09-00013" class="ref">
 <label class="label">64.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Li</surname>
    <given-names class="given-names">Q.Q.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Wang</surname>
    <given-names class="given-names">G.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Huang</surname>
    <given-names class="given-names">F.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Li</surname>
    <given-names class="given-names">J.M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Cuff</surname>
    <given-names class="given-names">C.F.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Reed</surname>
    <given-names class="given-names">E.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Sensitization of lung cancer cells to cisplatin by b-elemene is mediated through blockade of cell cycle progression: Antitumor efficacies of Î²-elemene and its synthetic analogs</article-title>
  <source class="source">Med. Oncol.</source>
  <year class="year">2013</year>
  <volume class="volume">30</volume>
  <fpage class="fpage">488</fpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1007/s12032-013-0488-9</pub-id>
  <?supplied-pmid 23397083?>
  <pub-id pub-id-type="pmid" class="pub-id">23397083</pub-id>
 </element-citation>
</ref>
